Literature DB >> 15588916

Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-alpha.

Fanny Boislève1, Saadia Kerdine-Römer, Marc Pallardy.   

Abstract

After application of haptens to the skin, immature dendritic cells (DC), also named Langerhans cells (LC), come into a maturation process, which include disappearance of specific molecules such as E-cadherin and Langerin and the expression of new molecules such as CD83, CD86 and CCR7. The involvement of p38 MAPK in DC maturation induced by haptens and TNF-alpha has already been shown, however, the role of the other MAPK, ERK and JNK, is less described. In this study, we demonstrated on human CD34(+)-derived DC that the three MAPK are participating to the expression of CD83, CD86 and CCR7 induced by nickel (NiSO(4)) but not to the down-regulation of E-cadherin and Langerin. In contrast, following TNF-alpha stimulation, only p38 MAPK is involved in CD83 and CCR7 expressions and ERK inhibits DC maturation while JNK inhibition had no effect. Our results also suggest that activation of p38 MAPK by TNF-alpha could partially suppress ERK activation and abrogates the inhibitory effect of ERK on DC maturation. In summary, the three MAPK pathways regulate DC maturation induced by haptens while only p38 MAPK seems to play a key role after TNF-alpha addition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15588916     DOI: 10.1016/j.tox.2004.08.015

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  17 in total

1.  Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.

Authors:  Martha L Bustos; Luai Huleihel; Maria G Kapetanaki; Christian L Lino-Cardenas; Lyle Mroz; Bryon M Ellis; Bryan J McVerry; Thomas J Richards; Naftali Kaminski; Nayra Cerdenes; Ana L Mora; Mauricio Rojas
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

2.  Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase (PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-mediated impairment of human dendritic cell maturation.

Authors:  Devram Sampat Ghorpade; Srini V Kaveri; Jagadeesh Bayry; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

3.  p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation.

Authors:  L Li; Z Huang; M Gillespie; P M Mroz; L A Maier
Journal:  Hum Immunol       Date:  2014-10-22       Impact factor: 2.850

4.  Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses.

Authors:  Kushagra Bansal; Akhauri Yash Sinha; Devram Sampat Ghorpade; Shambhuprasad Kotresh Togarsimalemath; Shripad A Patil; Srini V Kaveri; Kithiganahalli Narayanaswamy Balaji; Jagadeesh Bayry
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

5.  Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice.

Authors:  Heather D Cunningham; Laura A Shannon; Psachal A Calloway; Brian C Fassold; Irene Dunwiddie; George Vielhauer; Ming Zhang; Charlotte M Vines
Journal:  Transl Oncol       Date:  2010-12-01       Impact factor: 4.243

6.  Multiple protein kinase pathways mediate amplified IL-6 release by human lung fibroblasts co-exposed to nickel and TLR-2 agonist, MALP-2.

Authors:  Fei Gao; Kelly A Brant; Rachel M Ward; Richard T Cattley; Aaron Barchowsky; James P Fabisiak
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-17       Impact factor: 4.219

7.  High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.

Authors:  George V Aslanidi; Angela E Rivers; Luis Ortiz; Lakshmanan Govindasamy; Chen Ling; Giridhara R Jayandharan; Sergei Zolotukhin; Mavis Agbandje-McKenna; Arun Srivastava
Journal:  Vaccine       Date:  2012-04-10       Impact factor: 3.641

Review 8.  Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.

Authors:  Aswathy R Devan; Bhagyalakshmi Nair; Ayana R Kumar; Balachandran S Vinod; Lekshmi R Nath
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

9.  Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Authors:  Heather MacLeod; Navneet Bhasin; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

10.  A novel DC therapy with manipulation of MKK6 gene on nickel allergy in mice.

Authors:  Megumi Watanabe; Naozumi Ishimaru; Meinar Nur Ashrin; Rieko Arakaki; Akiko Yamada; Tetsuo Ichikawa; Yoshio Hayashi
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.